131 related articles for article (PubMed ID: 24852067)
1. Evaluating the patients with thalassemia major for long-term endocrinological complications after bone marrow transplantation.
Aldemir-Kocabaş B; Tezcan-Karasu G; Bircan I; Bircan O; Aktaş-Samur A; Yeşilipek MA
Pediatr Hematol Oncol; 2014 Oct; 31(7):616-23. PubMed ID: 24852067
[TBL] [Abstract][Full Text] [Related]
2. Growth and endocrine function following bone marrow transplantation for thalassemia major.
Li CK; Chik KW; Wong GW; Cheng PS; Lee V; Shing MM
Pediatr Hematol Oncol; 2004; 21(5):411-9. PubMed ID: 15205084
[TBL] [Abstract][Full Text] [Related]
3. Endocrinopathies in Turkish children with Beta thalassemia major: results from a single center study.
Isik P; Yarali N; Tavil B; Demirel F; Karacam GB; Sac RU; Fettah A; Ozkasap S; Kara A; Tunc B
Pediatr Hematol Oncol; 2014 Oct; 31(7):607-15. PubMed ID: 24854890
[TBL] [Abstract][Full Text] [Related]
4. Growth and endocrine function following bone marrow transplantation for thalassemia.
De Simone M; Olioso P; Di Bartolomeo P; Di Girolamo G; Farello G; Palumbo M; Papalinetti G; Bavaro P; Angrilli F; Torlontano G
Bone Marrow Transplant; 1995 Feb; 15(2):227-33. PubMed ID: 7773211
[TBL] [Abstract][Full Text] [Related]
5. High prevalence of endocrine dysfunction in long-term survivors after allogeneic bone marrow transplantation for hematologic diseases.
Tauchmanovà L; Selleri C; Rosa GD; Pagano L; Orio F; Lombardi G; Rotoli B; Colao A
Cancer; 2002 Sep; 95(5):1076-84. PubMed ID: 12209694
[TBL] [Abstract][Full Text] [Related]
6. Growth and endocrine function in children with acute myeloid leukaemia after bone marrow transplantation using busulfan/cyclophosphamide.
Afify Z; Shaw PJ; Clavano-Harding A; Cowell CT
Bone Marrow Transplant; 2000 May; 25(10):1087-92. PubMed ID: 10828870
[TBL] [Abstract][Full Text] [Related]
7. Bone mineral density in children with thalassaemia major: determining factors and effects of bone marrow transplantation.
Leung TF; Hung EC; Lam CW; Li CK; Chu Y; Chik KW; Shing MM; Lee V; Yuen PM
Bone Marrow Transplant; 2005 Aug; 36(4):331-6. PubMed ID: 15968288
[TBL] [Abstract][Full Text] [Related]
8. Endocrine function and bone disease during long-term chelation therapy with deferasirox in patients with β-thalassemia major.
Casale M; Citarella S; Filosa A; De Michele E; Palmieri F; Ragozzino A; Amendola G; Pugliese U; Tartaglione I; Della Rocca F; Cinque P; Nobili B; Perrotta S
Am J Hematol; 2014 Dec; 89(12):1102-6. PubMed ID: 25197009
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors in bone marrow transplantation for beta thalassemia major: experiences from Iran.
Ghavamzadeh A; Nasseri P; Eshraghian MR; Jahani M; Baybordi I; Nateghi J; Khodabandeh A; Sadjadi AR; Mohyeddin M; Khademi Y
Bone Marrow Transplant; 1998 Dec; 22(12):1167-9. PubMed ID: 9894719
[TBL] [Abstract][Full Text] [Related]
10. Low bone mineral density in adolescents with beta-thalassemia.
Vogiatzi MG; Autio KA; Mait JE; Schneider R; Lesser M; Giardina PJ
Ann N Y Acad Sci; 2005; 1054():462-6. PubMed ID: 16339698
[TBL] [Abstract][Full Text] [Related]
11. Transfusional iron burden and liver toxicity after bone marrow transplantation for acute myelogenous leukemia and hemoglobinopathies.
Jastaniah W; Harmatz P; Pakbaz Z; Fischer R; Vichinsky E; Walters MC
Pediatr Blood Cancer; 2008 Feb; 50(2):319-24. PubMed ID: 17557314
[TBL] [Abstract][Full Text] [Related]
12. Relation between BMD and biochemical, transfusion and endocrinological parameters in pediatric thalassemic patients.
Mohseni F; Mohajeri-Tehrani MR; Larijani B; Hamidi Z
Arch Osteoporos; 2014; 9():174. PubMed ID: 24652076
[TBL] [Abstract][Full Text] [Related]
13. Intravenous chelation therapy during transplantation for thalassemia.
Gaziev D; Giardini C; Angelucci E; Polchi P; Galimberti M; Baronciani D; Erer B; Maiello A; Lucarelli G
Haematologica; 1995; 80(4):300-4. PubMed ID: 7590497
[TBL] [Abstract][Full Text] [Related]
14. Peripheral blood versus bone marrow as a source of hematopoietic stem cells for allogeneic transplantation in children with class I and II beta thalassemia major.
Ghavamzadeh A; Iravani M; Ashouri A; Mousavi SA; Mahdavi N; Shamshiri A; Hadjibabaie M; Namdar R; Nedaeifard L; Ghaffari H; Alimoghaddam K
Biol Blood Marrow Transplant; 2008 Mar; 14(3):301-8. PubMed ID: 18275896
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow transplantation in thalassemia major patients using "short" anti-thymocyte globulin therapy in Shiraz, Southern Iran.
Zakerinia M; Khojasteh HN; Ramzi M; Haghshenas M
Transplant Proc; 2005 Dec; 37(10):4477-81. PubMed ID: 16387149
[TBL] [Abstract][Full Text] [Related]
16. Factors affecting gonadal function after bone marrow transplantation during childhood.
Couto-Silva AC; Trivin C; Thibaud E; Esperou H; Michon J; Brauner R
Bone Marrow Transplant; 2001 Jul; 28(1):67-75. PubMed ID: 11498747
[TBL] [Abstract][Full Text] [Related]
17. The impact of genotype on endocrine complications in thalassaemia major.
Skordis N; Michaelidou M; Savva SC; Ioannou Y; Rousounides A; Kleanthous M; Skordos G; Christou S
Eur J Haematol; 2006 Aug; 77(2):150-6. PubMed ID: 16800840
[TBL] [Abstract][Full Text] [Related]
18. Unexpected complications after bone marrow transplantation in transfusion-dependent children.
Saunders EF; Olivieri N; Freedman MH
Bone Marrow Transplant; 1993; 12 Suppl 1():88-90. PubMed ID: 8374573
[TBL] [Abstract][Full Text] [Related]
19. Results of therapy for beta-thalassemia major.
Lin KH; Lin KS
J Formos Med Assoc; 1992 Feb; 91(2):126-30. PubMed ID: 1364206
[TBL] [Abstract][Full Text] [Related]
20. Factors influencing outcome and incidence of late complications in children who underwent allogeneic hematopoietic stem cell transplantation for hemoglobinopathy.
Khalil A; Zaidman I; Elhasid R; Peretz-Nahum M; Futerman B; Ben-Arush M
Pediatr Hematol Oncol; 2012 Nov; 29(8):694-703. PubMed ID: 23020512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
